If you've just been diagnosed
A diagnosis of mild cognitive decline, early dementia, Alzheimer's, or Parkinson's doesn't mean the conversation is over. New regenerative-medicine protocols may slow, halt, or in some cases improve the trajectory of cognitive disease. The fastest way to know what's possible for your case is to start with a pre-consultation directly with Dr. TJ — he reviews your diagnosis, evaluates fit, and routes you to the right physician in our network.
Schedule your pre-consultation with Dr. TJ →A category of therapies — matched to your condition at consult. When conventional care plateaus, regenerative medicine extends what's possible.
Coordinated through our contracted licensed regenerative medicine practice. Nationwide mobile delivery. Clinician-supervised.
Regenerative medicine is a category of clinical intervention that goes beyond symptom management to target the underlying tissue damage driving chronic disease. Where conventional care manages symptoms — bronchodilators for COPD, diuretics for CHF, NSAIDs for joint pain — regenerative medicine protocols are designed to work at the tissue level, targeting the compartments where damage accumulates: pulmonary tissue, myocardial tissue, synovial and cartilage tissue, and neuronal tissue.
The conditions where regenerative medicine is most relevant are exactly those where conventional care plateaus. Chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), autoimmune flares, neurodegeneration, and post-injury chronic pain all share a common ceiling in standard care: symptom management without tissue restoration. Regenerative medicine solutions — protocols developed at our partner regenerative medicine practice — represent the frontier where actual restoration becomes possible.
Multiple administration routes (intra-articular, IV, nebulized, intrathecal, intranasal) allow targeting of nearly any tissue compartment, including the central nervous system. Delivery is nationwide via mobile clinical team — no specialized facility visit required. Each protocol is individually designed based on candidacy review, condition profile, and lab assessment. The pathway starts with a comprehensive 4M consult through My4MLife, which coordinates candidacy review and protocol design; the regenerative medicine itself is then provided directly by the contracted regenerative medicine clinic.
Regenerative medicine is not one procedure or one product. It is a category of clinical approaches — and that category has grown considerably. Different therapies are suited to different conditions, different stages of disease, and different patient profiles. The specific therapy or combination that best supports your condition is determined at the comprehensive 4M consult.
Short bioactive peptides signal specific repair and regenerative pathways at the cellular level. This category includes peptides that support tissue healing, neurological function, and systemic recovery. Often the entry-level approach within the regenerative medicine category — matched to candidacy at consult based on condition profile and prior interventions.
Concentrated bioactive protein arrays containing a broad spectrum of signaling proteins. Multiple administration routes — intravenous, intra-articular, nebulized, intrathecal — allow targeting of nearly any tissue compartment. These are coordinated through our partner regenerative medicine practice and matched to the condition and delivery compartment indicated by candidacy review.
A broader category encompassing cell-signaling and exosome-based approaches with a rapidly-evolving evidence base. These therapies work through biological signaling mechanisms that support tissue environments where conventional medicine has reached a structural ceiling. Candidacy is assessed individually — not all patients or conditions are appropriate for this tier of intervention.
A newer and rapidly-developing category. Gene-therapy approaches and related innovations are now reaching clinical availability for specific indications. This is an evolving frontier — new modalities are entering the landscape that were not available even recently. Where appropriate and clinically indicated, these emerging approaches are part of the category we coordinate access to through our partner practice.
No specific therapy is recommended or prescribed here. The right approach — whether a single modality or a combination protocol — is determined at the comprehensive 4M consult based on your medical history, condition, current state, and protocol design by our partner regenerative medicine practice.
Conditions we have helped include those where conventional care plateaus and regenerative medicine is the frontier. Listed for educational purposes — outcomes vary by individual.
Early-stage cognitive decline, post-concussion syndrome, and neurological aging — targeting CNS compartment via intrathecal and intranasal routes.
Osteoarthritis, cartilage degeneration, chronic joint pain that has not responded to physical therapy, NSAIDs, or anti-inflammatory protocols. Intra-articular delivery to the joint space.
Chronic obstructive pulmonary disease and pulmonary inflammation — addressed via nebulizer route for direct lung tissue access. A condition where conventional bronchodilator therapy manages but has not reversed the underlying process.
Congestive heart failure where conventional medical management has been optimized but a ceiling remains. Systemic IV protocol targeting whole-body inflammatory burden and cardiac tissue support.
Hashimoto's thyroiditis, Graves' disease, rheumatoid arthritis, lupus, and related autoimmune flare conditions — where immune dysregulation creates chronic tissue damage.
Long-standing pain that has not responded to physical therapy, medication, peptides like BPC-157, or anti-inflammatory diet. The regenerative option when standard interventions have been exhausted.
Chronic post-injury sequelae — including post-surgical recovery, post-concussion syndrome, stroke recovery, and injuries that have healed structurally but left persistent functional impairment.
Early Parkinson's-spectrum presentations, multiple sclerosis-related neurological impairment, chronic post-COVID, and related neurodegenerative processes where CNS compartment access is the therapeutic lever.
Chronic kidney disease where conventional nephrology management has reached a functional plateau. Systemic inflammatory burden reduction as a complement to standard CKD management.
Not every patient is a regenerative medicine candidate. This is a premium, clinician-designed protocol — appropriateness is determined through a structured review process, not a checkbox form.
Every regenerative medicine pathway begins with a comprehensive 4M consult through My4MLife. This covers your full health history, current medications, lab values, condition profile, and prior interventions. Regenerative medicine candidacy is assessed at this stage.
Schedule Your Consult →If candidacy is confirmed, your regenerative medicine protocol is designed in coordination with our partner regenerative medicine practice. Administration route selection (intra-articular, IV, nebulizer, intrathecal, intranasal), dosing, and scheduling are determined by condition and clinical profile.
The partner clinic's mobile team delivers your protocol at your location — home, office, or hotel — nationwide. A structured follow-up protocol monitors response and adjusts if a multi-administration course is indicated.
Protocol design, condition complexity, administration route, and number of sessions determine final pricing. This is not a one-size pricing model.
Regenerative medicine solutions are a premium service with pricing that reflects the mobile clinical team, clinician supervision, multi-route delivery model, and protocol complexity. Pricing is finalized at consult based on protocol design and candidacy.
Active members and Graduates receive priority scheduling and protocol guidance. Membership reduces coordination friction and ensures your consult is regenerative medicine-informed from the start.
The 20-Question Personal Risk Assessment captures broad health vectors but not specific chronic conditions. If you have a diagnosed condition like COPD, CHF, or autoimmune disease, schedule the comprehensive 4M consult — that's where condition-specific candidacy is determined.
Schedule the Comprehensive 4M Consult →Regenerative medicine candidacy is determined at the consult — not before. Start there.
Regenerative medicine protocols are coordinated through our partner regenerative medicine practice. My4MLife provides candidacy review through the comprehensive 4M consult; the regenerative medicine itself is delivered directly by the contracted clinical practice. My4MLife is a lifestyle and wellness education platform. Content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Outcomes vary by individual; the conditions we have helped are listed for educational purposes and do not constitute medical claims. Always consult a qualified healthcare provider before beginning any new health protocol. The regenerative medicine category includes therapies of varying evidence levels. Not all therapies are appropriate for all conditions; candidacy and protocol design are determined at the comprehensive 4M consult by our partner regenerative medicine practice.